110 related articles for article (PubMed ID: 30417943)
1. Prognostic impact of trisomy 21 in follicular lymphoma.
Mitsui T; Yokohama A; Koiso H; Saito A; Toyama K; Shimizu H; Ishizaki T; Irisawa H; Takizawa M; Saitoh T; Murayama K; Matsumoto M; Handa H; Hirato J; Kojima M; Murakami H; Tsukamoto N
Br J Haematol; 2019 Feb; 184(4):570-577. PubMed ID: 30417943
[TBL] [Abstract][Full Text] [Related]
2. Molecular cytogenetic analysis of follicular lymphoma (FL) provides detailed characterization of chromosomal instability associated with the t(14;18)(q32;q21) positive and negative subsets and histologic progression.
Nanjangud G; Rao PH; Teruya-Feldstein J; Donnelly G; Qin J; Mehra S; Jhanwar SC; Zelenetz AD; Chaganti RS
Cytogenet Genome Res; 2007; 118(2-4):337-44. PubMed ID: 18000388
[TBL] [Abstract][Full Text] [Related]
3. Detection of chromosomal abnormalities by G-banding and prognostic impact in follicular lymphoma in the rituximab era.
Tsukamoto T; Kiyota M; Kawata E; Uoshima N; Tatekawa S; Chinen Y; Nagoshi H; Mizutani S; Shimura Y; Yamamoto-Sugitani M; Kobayashi T; Horiike S; Yasukawa S; Yanagisawa A; Taniwaki M; Kuroda J
Int J Hematol; 2017 May; 105(5):658-667. PubMed ID: 27995457
[TBL] [Abstract][Full Text] [Related]
4. The 3q27 and 18q21 translocations for follicular lymphoma and diffuse large B-cell lymphoma in the rituximab era.
Watanabe R; Tomita N; Matsumoto C; Hattori Y; Matsuura S; Takasaki H; Hashimoto C; Fujita H; Fujisawa S; Ishigatsubo Y
J Clin Exp Hematop; 2013; 53(2):107-14. PubMed ID: 23995106
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of chromosomal abnormalities in follicular lymphoma.
Tilly H; Rossi A; Stamatoullas A; Lenormand B; Bigorgne C; Kunlin A; Monconduit M; Bastard C
Blood; 1994 Aug; 84(4):1043-9. PubMed ID: 8049424
[TBL] [Abstract][Full Text] [Related]
6. A marginal zone phenotype in follicular lymphoma with t(14;18) is associated with secondary cytogenetic aberrations typical of marginal zone lymphoma.
Torlakovic EE; Aamot HV; Heim S
J Pathol; 2006 Jun; 209(2):258-64. PubMed ID: 16583359
[TBL] [Abstract][Full Text] [Related]
7. Non-Hodgkin lymphoma with t(14;18): clonal evolution patterns and cytogenetic-pathologic-clinical correlations.
Aamot HV; Torlakovic EE; Eide MB; Holte H; Heim S
J Cancer Res Clin Oncol; 2007 Jul; 133(7):455-70. PubMed ID: 17235551
[TBL] [Abstract][Full Text] [Related]
8. [Characteristics and Prognostic Significance of Cytogenetic Abnormalities in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement].
Liu W; Lyu R; Huang WY; Li CW; Liu H; Li J; Zou DH; Qiu LG; Yi SH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):761-765. PubMed ID: 28641631
[TBL] [Abstract][Full Text] [Related]
9. Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.
Jaime-Pérez JC; Gamboa-Alonso CM; Vázquez-Mellado de Larracoechea A; Rodríguez-Martínez M; Gutiérrez-Aguirre CH; Marfil-Rivera LJ; Gómez-Almaguer D
Arch Med Res; 2015 Aug; 46(6):454-61. PubMed ID: 26235285
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal analyses of 52 cases of follicular lymphoma with t(14;18), including blastic/blastoid variant.
Mohamed AN; Palutke M; Eisenberg L; Al-Katib A
Cancer Genet Cytogenet; 2001 Apr; 126(1):45-51. PubMed ID: 11343778
[TBL] [Abstract][Full Text] [Related]
11. Multicolour fluorescence in situ hybridization analysis of t(14;18)-positive follicular lymphoma and correlation with gene expression data and clinical outcome.
Lestou VS; Gascoyne RD; Sehn L; Ludkovski O; Chhanabhai M; Klasa RJ; Husson H; Freedman AS; Connors JM; Horsman DE
Br J Haematol; 2003 Sep; 122(5):745-59. PubMed ID: 12930384
[TBL] [Abstract][Full Text] [Related]
12. A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts.
Huet S; Tesson B; Jais JP; Feldman AL; Magnano L; Thomas E; Traverse-Glehen A; Albaud B; Carrère M; Xerri L; Ansell SM; Baseggio L; Reyes C; Tarte K; Boyault S; Haioun C; Link BK; Feugier P; Lopez-Guillermo A; Tilly H; Brice P; Hayette S; Jardin F; Offner F; Sujobert P; Gentien D; Viari A; Campo E; Cerhan JR; Salles G
Lancet Oncol; 2018 Apr; 19(4):549-561. PubMed ID: 29475724
[TBL] [Abstract][Full Text] [Related]
13. Prediction of high risk for death in patients with follicular lymphoma receiving rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in first-line chemotherapy.
Murakami S; Kato H; Higuchi Y; Yamamoto K; Yamamoto H; Saito T; Taji H; Yatabe Y; Nakamura S; Kinoshita T
Ann Hematol; 2016 Aug; 95(8):1259-69. PubMed ID: 27220639
[TBL] [Abstract][Full Text] [Related]
14. [Clinical Features, Treatment and Prognostic Factors of 94 Patients with Follicular Lymphoma].
DU XY; Hu K; Zhao W; Yang P; Wan W; Jing HM; Ke XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):756-764. PubMed ID: 29950216
[TBL] [Abstract][Full Text] [Related]
15. Addition of Rituximab to Involved-Field Radiation Therapy Prolongs Progression-free Survival in Stage I-II Follicular Lymphoma: Results of a Multicenter Study.
Ruella M; Filippi AR; Bruna R; Di Russo A; Magni M; Caracciolo D; Passera R; Matteucci P; Di Nicola M; Corradini P; Parvis G; Gini G; Olivieri A; Ladetto M; Ricardi U; Tarella C; Devizzi L
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):783-91. PubMed ID: 26972651
[TBL] [Abstract][Full Text] [Related]
16. Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18).
Horsman DE; Connors JM; Pantzar T; Gascoyne RD
Genes Chromosomes Cancer; 2001 Apr; 30(4):375-82. PubMed ID: 11241790
[TBL] [Abstract][Full Text] [Related]
17. SNP analysis of minimally evolved t(14;18)(q32;q21)-positive follicular lymphomas reveals a common copy-neutral loss of heterozygosity pattern.
Cheung KJ; Rogic S; Ben-Neriah S; Boyle M; Connors JM; Gascoyne RD; Horsman DE
Cytogenet Genome Res; 2012; 136(1):38-43. PubMed ID: 22104078
[TBL] [Abstract][Full Text] [Related]
18. Clonal evolution in t(14;18)-positive follicular lymphoma, evidence for multiple common pathways, and frequent parallel clonal evolution.
d'Amore F; Chan E; Iqbal J; Geng H; Young K; Xiao L; Hess MM; Sanger WG; Smith L; Wiuf C; Hagberg O; Fu K; Chan WC; Dave BJ
Clin Cancer Res; 2008 Nov; 14(22):7180-7. PubMed ID: 19010834
[TBL] [Abstract][Full Text] [Related]
19. Cytologic differential diagnosis of follicular lymphoma grades 1 and 2 from reactive follicular hyperplasia: cytologic features of fine-needle aspiration smears with Pap stain and fluorescence in situ hybridization analysis to detect t(14;18)(q32;q21) chromosomal translocation.
Kishimoto K; Kitamura T; Fujita K; Tate G; Mitsuya T
Diagn Cytopathol; 2006 Jan; 34(1):11-7. PubMed ID: 16355396
[TBL] [Abstract][Full Text] [Related]
20. Impact of the introduction of rituximab in first-line follicular lymphoma: a retrospective study of 247 unselected patients referred to a single institution with a long-term follow-up.
Nicolas-Virelizier E; Ségura-Ferlay C; Ghesquières H; Chassagne-Clément C; Gargi T; Biron P; Belhabri A; Rey P; Faurie P; Chabaud S; Sebban C
Hematol Oncol; 2015 Mar; 33(1):1-8. PubMed ID: 24496668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
